文献速递肝病

干扰素诱导的IL-10驱动慢性肝损伤期间全身性T细胞功能障碍

Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury.
PubMed 文献 · J Hepatol · 2023-03-02

慢性肝病(CLD)患者对病毒感染和疫苗接种反应低下。研究结合胆管结扎(BDL)和四氯化碳(CCl4)肝损伤小鼠模型及临床试验,发现肠道菌群易位诱导肝脏髓系细胞产生IFN-I,进而触发过量IL-10,使抗原特异性T细胞功能障碍;阻断IL-10R可恢复肝硬化患者T细胞功能。

要点

  • 慢性肝损伤小鼠对疫苗接种和病毒感染产生T细胞反应缺陷,导致持续感染。
  • 肠道菌群易位固有感知诱导肝脏髓系细胞IFN-I信号,病毒感染的触发过量IL-10。
  • 阻断IL-10Ra可恢复疫苗接种肝硬化患者T细胞的功能表型。

核心结论

  • 肠道菌群易位的固有感知诱导IFN-I/IL-10表达,驱动长期肝损伤期间全身性T细胞免疫丧失。

研究设计与样本

  • 研究结合BDL和CCl4肝损伤小鼠模型,使用髓系细胞缺乏IFN-I(LysM-Cre IFNARflox/flox)、IFNAR诱导的IL-10(MX1-Cre IL10flox/flox)或T细胞IL-10R(CD4-DN IL-10R)转基因小鼠,并进行疫苗接种或淋巴细胞脉络丛脑膜炎病毒感染。
  • 在概念验证临床研究中,评估CLD患者和健康个体接种HBV和SARS-CoV-2疫苗后的T细胞反应和抗体滴度。
  • 体内使用特异性抗体(抗IFNAR和抗IL10R)阻断关键通路。

主要发现

  • BDL和CCl4诱导的长期肝损伤导致小鼠对疫苗接种和病毒感染的T细胞反应受损,随后导致持续感染。
  • 在肝硬化患者中观察到类似的疫苗接种T细胞反应缺陷。
  • 转位肠道菌群的固有感知诱导肝脏髓系细胞IFN-I信号,在病毒感染时触发过量IL-10产生。
  • 抗原特异性T细胞中的IL-10R信号使其功能失调。
  • 抗生素治疗和抑制IFNAR或IL-10Ra可恢复小鼠抗病毒免疫,未检测到免疫病理。

临床怎么用

  • 鉴于干扰IL-10R后未出现免疫病理,研究强调了一个潜在新靶点,可在未来临床研究中探索以重建CLD患者的T细胞免疫。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Patients with chronic liver disease (CLD), including cirrhosis, are at increased risk of intractable viral infections and are hyporesponsive to vaccination. Hallmarks of CLD and cirrhosis include microbial translocation and elevated levels of type I interferon (IFN-I). We aimed to investigate the relevance of microbiota-induced IFN-I in the impaired adaptive immune responses observed in CLD. METHODS: We combined bile duct ligation (BDL) and carbon tetrachloride (CCl4) models of liver injury with vaccination or lymphocytic choriomeningitis virus infection in transgenic mice lacking IFN-I in myeloid cells (LysM-Cre IFNARflox/flox), IFNAR-induced IL-10 (MX1-Cre IL10flox/flox) or IL-10R in T cells (CD4-DN IL-10R). Key pathways were blocked in vivo with specific antibodies (anti-IFNAR and anti-IL10R). We assessed T-cell responses and antibody titers after HBV and SARS-CoV-2 vaccinations in patients with CLD and healthy individuals in a proof-of-concept clinical study. RESULTS: We demonstrate that BDL- and CCL4-induced prolonged liver injury leads to impaired T-cell responses to vaccination and viral infection in mice, subsequently leading to persistent infection. We observed a similarly defective T-cell response to vaccination in patients with cirrhosis. Innate sensing of translocated gut microbiota induced IFN-I signaling in hepatic myeloid cells that triggered excessive IL-10 production upon viral infection. IL-10R signaling in antigen-specific T cells rendered them dysfunctional. Antibiotic treatment and inhibition of IFNAR or IL-10Ra restored antiviral immunity without detectable immune pathology in mice. Notably, IL-10Ra blockade restored the functional phenotype of T cells from vaccinated patients with cirrhosis. CONCLUSION: Innate sensing of translocated microbiota induces IFN-/IL-10 expression, which drives the loss of systemic T-cell immunity during prolonged liver injury. IMPACT AND IMPLICATIONS: Chronic liver injury and cirrhosis are associated with enhanced susceptibility to viral infections and vaccine hyporesponsiveness. Using different preclinical animal models and patient samples, we identified that impaired T-cell immunity in BDL- and CCL4-induced prolonged liver injury is driven by sequential events involving microbial translocation, IFN signaling leading to myeloid cell-induced IL-10 expression, and IL-10 signaling in antigen-specific T cells. Given the absence of immune pathology after interference with IL-10R, our study highlights a potential novel target to reconstitute T-cell immunity in patients with CLD that can be explored in future clinical studies.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Hackstein CP, Spitzer J, Symeonidis K, et al. Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury. J Hepatol. 2023. PMID: 36870611. doi:10.1016/j.jhep.2023.02.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。